Cargando…

Initial evaluation of (4S)-4-(3-[(18)F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma

PURPOSE: (4S)-4-(3-[(18)F]Fluoropropyl)-l-glutamic acid ([(18)F]FSPG) measures system x(C)(−) transporter activity and shows promise for oncologic imaging. We present data on tumor uptake of this radiopharmaceutical in human subjects with head and neck cancer (HNC), colorectal cancer (CRC), and non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sonya Y., Mosci, Camila, Kumar, Meena, Wardak, Mirwais, Koglin, Norman, Bullich, Santiago, Mueller, Andre, Berndt, Mathias, Stephens, Andrew W., Chin, Frederick T., Gambhir, Sanjiv S., Mittra, Erik S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455665/ https://www.ncbi.nlm.nih.gov/pubmed/32857284 http://dx.doi.org/10.1186/s13550-020-00678-2

Ejemplares similares

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
por: Mittra, Erik S., et al.
Publicado: (2016)

Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[(18)F]fluoropropyl)-L-glutamic acid ([(18)F]FSPG) for clinical use
por: Shih, Kai-Ting, et al.
Publicado: (2020)

Radiosynthesis and Analysis of (S)-4-(3-[(18)F]Fluoropropyl)-L-Glutamic Acid
por: Brown, Gavin, et al.
Publicado: (2022)

[(18)F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis
por: Hoehne, Aileen, et al.
Publicado: (2018)

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
por: Wu, Zehui, et al.
Publicado: (2014)

Robust and Facile Automated Radiosynthesis of [(18)F]FSPG on the GE FASTlab
por: Edwards, Richard, et al.
Publicado: (2021)

(18)F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules
por: Paez, Rafael, et al.
Publicado: (2022)

Simplified and Highly-reliable automated production of [(18)F]FSPG for clinical studies
por: Lin, Mai, et al.
Publicado: (2023)

Simplified and highly-reliable automated production of [(18)F]FSPG for clinical studies
por: Lin, Mai, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of O-[3-(18)F-fluoropropyl]-α-methyl Tyrosine in Mesothelioma-Bearing Rodents
por: Shih, I-Hong, et al.
Publicado: (2013)

Feasibility of [(18)F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type KRAS Colorectal Cancer
por: Bae, Seong-Woo, et al.
Publicado: (2023)

PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats
por: Domercq, Maria, et al.
Publicado: (2016)

PET Imaging a MPTP-Induced Mouse Model of Parkinson’s Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [(18)F]-DTBZ (AV-133)
por: Toomey, James S., et al.
Publicado: (2012)

A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson’s Disease Quantification
por: Pan, Yiwei, et al.
Publicado: (2022)

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
por: Wan, Zhuoya, et al.
Publicado: (2021)

Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo (18)F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging
por: Weng, Chi-Chang, et al.
Publicado: (2017)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

Hodgkin's Disease and the Lymphomas Vol. 4
por: Blackledge, G.
Publicado: (1982)

Hodgkin's Disease and the Lymphomas, Vol. 4
por: Blackledge, G.
Publicado: (1982)

Breast imaging technology: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects - applications to breast cancer
por: Berger, Frank, et al.
Publicado: (2001)

Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma
por: Frieboes, Hermann B., et al.
Publicado: (2015)

Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
por: Bullich, Santiago, et al.
Publicado: (2017)

Automated VOI Analysis in FDDNP PET Using Structural Warping: Validation through Classification of Alzheimer's Disease Patients
por: Wilks, Moses Q., et al.
Publicado: (2012)

Atlas of Breast Cancer, Second Edition
por: Mittra, I
Publicado: (2001)

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study
por: Bullich, Santiago, et al.
Publicado: (2022)

Discovery of a Neuroprotective Chemical, (S)-N-(3-(3,6-Dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(−)-P7C3-S243], with Improved Druglike Properties
por: Naidoo, Jacinth, et al.
Publicado: (2014)

Glutamate and its receptors in cancer
por: Stepulak, Andrzej, et al.
Publicado: (2014)

(18)F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT
por: Baratto, Lucia, et al.
Publicado: (2017)

Role of Glutathione Peroxidase 4 in Glutamate-Induced Oxytosis in the Retina
por: Sakai, Osamu, et al.
Publicado: (2015)

Dissociation of impulsive traits by subthalamic metabotropic glutamate receptor 4
por: Piszczek, Lukasz, et al.
Publicado: (2022)

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2022)

Commentary to (18)F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
por: Stephens, Andrew W., et al.
Publicado: (2018)

Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality
por: Sonni, Ida, et al.
Publicado: (2018)

Aquaporin 4-Mediated Glutamate-Induced Astrocyte Swelling Is Partially Mediated through Metabotropic Glutamate Receptor 5 Activation
por: Shi, Zhongfang, et al.
Publicado: (2017)

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
por: Nguyen, Tu, et al.
Publicado: (2019)

Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
por: Jovalekic, Aleksandar, et al.
Publicado: (2023)

Cancer Screening: A Mathematical Model Relating Secreted Blood Biomarker Levels to Tumor Sizes
por: Lutz, Amelie M, et al.
Publicado: (2008)

Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes
por: Spampinato, Simona Federica, et al.
Publicado: (2015)

Glutamate in cancers: from metabolism to signaling
por: Yi, Haowei, et al.
Publicado: (2020)

The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer
por: Kuribayashi, Nobuyuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_trvtsj05o356gurrqq3vlq7bkm